Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)
CNY 13.8
(0.73%)
CNY 13.8
(0.73%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.93 Billion CNY | -0.73% |
| 2022 | 3.96 Billion CNY | -3.2% |
| 2021 | 4.09 Billion CNY | 5.5% |
| 2020 | 3.88 Billion CNY | 13.66% |
| 2019 | 3.41 Billion CNY | 0.28% |
| 2018 | 3.4 Billion CNY | 5.47% |
| 2017 | 3.22 Billion CNY | 12.53% |
| 2016 | 2.86 Billion CNY | 3.99% |
| 2015 | 2.75 Billion CNY | -0.86% |
| 2014 | 2.78 Billion CNY | 3.51% |
| 2013 | 2.68 Billion CNY | 8.21% |
| 2012 | 2.48 Billion CNY | 12.91% |
| 2011 | 2.2 Billion CNY | 11.09% |
| 2010 | 1.98 Billion CNY | -3.91% |
| 2009 | 2.06 Billion CNY | 76.87% |
| 2008 | 1.16 Billion CNY | 8.06% |
| 2007 | 1.07 Billion CNY | 29.7% |
| 2006 | 831.81 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.8 Billion CNY | 0.04% |
| 2024 Q3 | 3.93 Billion CNY | 3.32% |
| 2024 Q1 | 3.8 Billion CNY | -3.29% |
| 2023 Q3 | 3.82 Billion CNY | 1.36% |
| 2023 Q4 | 3.93 Billion CNY | 2.82% |
| 2023 Q1 | 4.12 Billion CNY | 3.95% |
| 2023 Q2 | 3.77 Billion CNY | -8.37% |
| 2023 FY | 3.93 Billion CNY | -0.73% |
| 2022 FY | 3.96 Billion CNY | -3.2% |
| 2022 Q3 | 4.04 Billion CNY | -0.84% |
| 2022 Q2 | 4.08 Billion CNY | -2.43% |
| 2022 Q4 | 3.96 Billion CNY | -2.01% |
| 2022 Q1 | 4.18 Billion CNY | 2.1% |
| 2021 Q2 | 3.9 Billion CNY | -2.31% |
| 2021 Q4 | 4.09 Billion CNY | 1.86% |
| 2021 FY | 4.09 Billion CNY | 5.5% |
| 2021 Q1 | 3.99 Billion CNY | 2.97% |
| 2021 Q3 | 4.02 Billion CNY | 2.96% |
| 2020 Q1 | 3.53 Billion CNY | 3.49% |
| 2020 Q3 | 3.68 Billion CNY | 2.58% |
| 2020 Q4 | 3.88 Billion CNY | 5.22% |
| 2020 Q2 | 3.59 Billion CNY | 1.76% |
| 2020 FY | 3.88 Billion CNY | 13.66% |
| 2019 Q1 | 3.38 Billion CNY | -0.48% |
| 2019 FY | 3.41 Billion CNY | 0.28% |
| 2019 Q4 | 3.41 Billion CNY | 4.38% |
| 2019 Q3 | 3.27 Billion CNY | 0.96% |
| 2019 Q2 | 3.24 Billion CNY | -4.39% |
| 2018 Q2 | 3.1 Billion CNY | -5.06% |
| 2018 Q4 | 3.4 Billion CNY | 5.13% |
| 2018 Q3 | 3.23 Billion CNY | 4.19% |
| 2018 Q1 | 3.27 Billion CNY | 1.42% |
| 2018 FY | 3.4 Billion CNY | 5.47% |
| 2017 Q1 | 3 Billion CNY | 4.72% |
| 2017 Q2 | 2.93 Billion CNY | -2.41% |
| 2017 Q3 | 3.05 Billion CNY | 4.01% |
| 2017 Q4 | 3.22 Billion CNY | 5.87% |
| 2017 FY | 3.22 Billion CNY | 12.53% |
| 2016 Q2 | 2.61 Billion CNY | -7.35% |
| 2016 Q4 | 2.86 Billion CNY | 6.21% |
| 2016 Q1 | 2.81 Billion CNY | 2.17% |
| 2016 FY | 2.86 Billion CNY | 3.99% |
| 2016 Q3 | 2.7 Billion CNY | 3.43% |
| 2015 Q4 | 2.75 Billion CNY | 7.0% |
| 2015 Q3 | 2.57 Billion CNY | 1.71% |
| 2015 Q2 | 2.53 Billion CNY | -8.53% |
| 2015 Q1 | 2.77 Billion CNY | -0.41% |
| 2015 FY | 2.75 Billion CNY | -0.86% |
| 2014 Q1 | 2.74 Billion CNY | 1.91% |
| 2014 FY | 2.78 Billion CNY | 3.51% |
| 2014 Q4 | 2.78 Billion CNY | 2.85% |
| 2014 Q3 | 2.7 Billion CNY | 6.62% |
| 2014 Q2 | 2.53 Billion CNY | -7.37% |
| 2013 Q2 | 2.41 Billion CNY | -6.59% |
| 2013 Q1 | 2.59 Billion CNY | 4.24% |
| 2013 Q3 | 2.58 Billion CNY | 6.73% |
| 2013 Q4 | 2.68 Billion CNY | 4.12% |
| 2013 FY | 2.68 Billion CNY | 8.21% |
| 2012 Q3 | 2.34 Billion CNY | 4.74% |
| 2012 FY | 2.48 Billion CNY | 12.91% |
| 2012 Q1 | 2.29 Billion CNY | 4.34% |
| 2012 Q2 | 2.23 Billion CNY | -2.62% |
| 2012 Q4 | 2.48 Billion CNY | 6.1% |
| 2011 FY | 2.2 Billion CNY | 11.09% |
| 2011 Q4 | 2.2 Billion CNY | 4.04% |
| 2011 Q2 | 2.02 Billion CNY | -1.36% |
| 2011 Q1 | 2.05 Billion CNY | 3.79% |
| 2011 Q3 | 2.11 Billion CNY | 4.3% |
| 2010 FY | 1.98 Billion CNY | -3.91% |
| 2010 Q1 | 1.8 Billion CNY | -12.58% |
| 2010 Q4 | 1.98 Billion CNY | 6.2% |
| 2010 Q3 | 1.86 Billion CNY | 0.59% |
| 2010 Q2 | 1.85 Billion CNY | 2.89% |
| 2009 FY | 2.06 Billion CNY | 76.87% |
| 2009 Q3 | 1.85 Billion CNY | 71.83% |
| 2009 Q4 | 2.06 Billion CNY | 11.05% |
| 2009 Q2 | 1.08 Billion CNY | 0.0% |
| 2008 Q4 | 1.16 Billion CNY | 0.0% |
| 2008 FY | 1.16 Billion CNY | 8.06% |
| 2007 FY | 1.07 Billion CNY | 29.7% |
| 2006 FY | 831.81 Million CNY | 0.0% |